Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Clinical Therapeutics|April 28, 2004
Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trialAllan I Bloom, Michael Y Shapira, Reuven Or, et al.
Clinical Transplantation|November 30, 2005
Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimenIgor B Resnick, Ali Abdul Hai, Michael Y Shapira, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study GroupMark S Freedman, Amit Bar-Or, Harold L Atkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patientsIgor B Resnick, Panagiotis D Tsirigotis, Michael Y Shapira, et al.
Cellular Signalling|March 29, 2011
Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressionsSarit Kahana, Susan Finniss, Simona Cazacu, et al.
Haematologica|February 5, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow TransplantationMohamad Mohty, Myriam Labopin, Reza Tabrizzi, et al.
Immunotherapy|July 20, 2010
Post-hematopoietic stem cell transplantion immune-mediated cytopeniasPanagiotis D Tsirigotis, Igor B Resnick, Reuven Or, et al.
Plos One|February 18, 2010
Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanismsOrit Uziel, Einat Beery, Vladimir Dronichev, et al.
International Journal of Cancer|January 6, 2010
Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experienceJacques-Olivier Bay, Aurélie Cabrespine-Faugeras, Reza Tabrizi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantationMenachem Bitan, Reuven Or, Michael Y Shapira, et al.
Pageof 14